Will spread through air spaces be a staging parameter in lung cancer?

Targeting MET in Lung Cancer: Will Expectations Finally Be MET?

The hepatocyte growth factor receptor (MET) is a potential therapeutic target in a number of cancers, including NSCLC. In NSCLC, MET pathway activation is thought to occur through a diverse set of mechanisms that influence properties affecting cancer cell survival, growth, and invasiveness. Preclinical and clinical evidence suggests a role for MET activation as both a primary oncogenic driver i...

This number will be updated

Lung cancer staging

During this interactive hands-on workshop the participants will view complete imaging examinations (CT of chest, abdomen, brain, MRI of brain, chest, adrenals, musculoskeletal system, PET-CT, bone scintigraphy etc.) on workstations in a clinical routine setting and discuss findings with two tutors. Cases will include those with typical findings as well as pitfalls and problems. Particular atten...

Staging of lung cancer.

arl in the history of thoracic surgery, attempts were made to classify patients as to the extent of disease, in order to avoid unnecessary surgery. Evarts A. Graham,1 the surgeon who first successfully removed a carcinomatous lung in 1933, listed in 1944 the following signs of inoperabiity: (1) the presence of a bloody pleural effusion; (2) paralysis of the ipsilateral hemidiaphragm; (3) paraly...

PETCT in lung cancer staging